Accuray Incorporated (ARAY) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Accuray Incorporated (ARAY) has a cash flow conversion efficiency ratio of 0.058x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.43 Million) by net assets ($41.70 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Accuray Incorporated worth for the company's overall valuation and market capitalisation.
Accuray Incorporated - Cash Flow Conversion Efficiency Trend (2005–2026)
This chart illustrates how Accuray Incorporated's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Accuray Incorporated Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Accuray Incorporated ranked by their cash flow conversion efficiency. Explore Accuray Incorporated cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Reading International B Inc
NASDAQ:RDIB
|
0.097x |
|
Sangamo Therapeutics Inc
NASDAQ:SGMO
|
-4.565x |
|
C-Com Satellite Systems Inc.
V:CMI
|
-0.001x |
|
Bowen Acquisition Corp Ordinary Shares
NASDAQ:BOWN
|
0.000x |
|
FORCS Co.Ltd
KQ:189690
|
0.034x |
|
Spencer's Retail Limited
NSE:SPENCERS
|
0.084x |
|
Hove AS
CO:HOVE
|
-0.033x |
|
Crown Crafts Inc
NASDAQ:CRWS
|
0.137x |
Annual Cash Flow Conversion Efficiency for Accuray Incorporated (2005–2026)
The table below shows the annual cash flow conversion efficiency of Accuray Incorporated from 2005 to 2026. View latest Accuray Incorporated stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-06-30 | $41.70 Million | $-6.98 Million | -0.167x | -575.13% |
| 2025-06-30 | $81.17 Million | $2.86 Million | 0.035x | +113.34% |
| 2024-06-30 | $45.08 Million | $-11.90 Million | -0.264x | -191.18% |
| 2023-06-30 | $53.66 Million | $15.54 Million | 0.290x | +741.79% |
| 2022-06-30 | $53.19 Million | $-2.40 Million | -0.045x | -108.07% |
| 2021-06-30 | $68.84 Million | $38.51 Million | 0.559x | +2523.42% |
| 2020-06-30 | $63.63 Million | $-1.47 Million | -0.023x | +96.12% |
| 2019-06-30 | $49.87 Million | $-29.64 Million | -0.594x | -257.68% |
| 2018-06-30 | $48.63 Million | $18.33 Million | 0.377x | +4715.74% |
| 2017-06-30 | $46.53 Million | $-380.00K | -0.008x | -101.45% |
| 2016-06-30 | $59.66 Million | $33.54 Million | 0.562x | +354.59% |
| 2015-06-30 | $75.78 Million | $-16.73 Million | -0.221x | -6389.14% |
| 2014-06-30 | $98.55 Million | $346.00K | 0.004x | +100.57% |
| 2013-06-30 | $106.83 Million | $-66.18 Million | -0.619x | -229.90% |
| 2012-06-30 | $203.87 Million | $-38.28 Million | -0.188x | -463.82% |
| 2011-06-30 | $240.33 Million | $12.40 Million | 0.052x | +273.02% |
| 2010-06-30 | $170.08 Million | $-5.07 Million | -0.030x | +42.95% |
| 2009-06-30 | $153.90 Million | $-8.05 Million | -0.052x | +62.00% |
| 2008-06-30 | $130.76 Million | $-17.99 Million | -0.138x | -248.81% |
| 2007-06-30 | $125.44 Million | $11.60 Million | 0.092x | +129.31% |
| 2006-06-30 | $-80.86 Million | $25.50 Million | -0.315x | +1.64% |
| 2005-06-30 | $-56.17 Million | $18.02 Million | -0.321x | -- |
About Accuray Incorporated
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more